Global Sterile Injectable CDMO Market Growth (Status and Outlook) 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
A Contract Development and Manufacturing Organization (CDMO) that specializes in sterile injectables focuses on the development and manufacturing of injectable drugs in a sterile environment. These organizations typically offer services ranging from formulation development to final sterile fill and finish. They adhere to strict regulatory standards to ensure the safety, efficacy, and quality of the injectable products they produce. Sterile injectables are crucial for various medical applications, including intravenous, intramuscular, and subcutaneous administration of medications. A CDMO specializing in this area plays a vital role in bringing these essential pharmaceutical products to market.
The global Sterile Injectable CDMO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sterile Injectable CDMO Industry Forecast” looks at past sales and reviews total world Sterile Injectable CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Sterile Injectable CDMO sales for 2023 through 2029. With Sterile Injectable CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Injectable CDMO industry.
This Insight Report provides a comprehensive analysis of the global Sterile Injectable CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sterile Injectable CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Injectable CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Injectable CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Injectable CDMO.
United States market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sterile Injectable CDMO players cover Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Injectable CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
A Contract Development and Manufacturing Organization (CDMO) that specializes in sterile injectables focuses on the development and manufacturing of injectable drugs in a sterile environment. These organizations typically offer services ranging from formulation development to final sterile fill and finish. They adhere to strict regulatory standards to ensure the safety, efficacy, and quality of the injectable products they produce. Sterile injectables are crucial for various medical applications, including intravenous, intramuscular, and subcutaneous administration of medications. A CDMO specializing in this area plays a vital role in bringing these essential pharmaceutical products to market.
The global Sterile Injectable CDMO market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.
LPI (LP Information)' newest research report, the “Sterile Injectable CDMO Industry Forecast” looks at past sales and reviews total world Sterile Injectable CDMO sales in 2022, providing a comprehensive analysis by region and market sector of projected Sterile Injectable CDMO sales for 2023 through 2029. With Sterile Injectable CDMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sterile Injectable CDMO industry.
This Insight Report provides a comprehensive analysis of the global Sterile Injectable CDMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sterile Injectable CDMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sterile Injectable CDMO market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sterile Injectable CDMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sterile Injectable CDMO.
United States market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Sterile Injectable CDMO is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Sterile Injectable CDMO players cover Abbvie, Famar, Polfa Tarchomin, Pfizer, Quotient Sciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Sterile Injectable CDMO market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Preclinical Manufacturing
- Clinical Manufacturing
- Commercial Manufacturing
- Pharmaceutical Company
- Research Institute
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Preclinical Manufacturing
- Clinical Manufacturing
- Commercial Manufacturing
- Pharmaceutical Company
- Research Institute
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbvie
- Famar
- Polfa Tarchomin
- Pfizer
- Quotient Sciences
- Temad Co.
- Tianjin Hankang Pharmaceutical Biotechnology
- Fareva
- Sharp
- Astral SteriTech
- Evonik
- Aurigene Pharmaceutical Services
- Prague Scientific
- Ethypharm
- TriRx Pharmaceutical Services
- Biophrama Group
- Gensenta Pharmaceuticals
- BioTechnique
- Mithra CDMo
- S.C. Rompharm Company SRL
- Flagship Biotech International Pvt. Ltd
- Curida AS
- BirgiMefar Group
- Brooks Laboratories Limited
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sterile Injectable CDMO Market Size 2019-2030
2.1.2 Sterile Injectable CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sterile Injectable CDMO by Country/Region, 2019, 2023 & 2030
2.2 Sterile Injectable CDMO Segment by Type
2.2.1 Preclinical Manufacturing
2.2.2 Clinical Manufacturing
2.2.3 Commercial Manufacturing
2.3 Sterile Injectable CDMO Market Size by Type
2.3.1 Sterile Injectable CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
2.4 Sterile Injectable CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Research Institute
2.4.3 Other
2.5 Sterile Injectable CDMO Market Size by Application
2.5.1 Sterile Injectable CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
3 STERILE INJECTABLE CDMO MARKET SIZE BY PLAYER
3.1 Sterile Injectable CDMO Market Size Market Share by Player
3.1.1 Global Sterile Injectable CDMO Revenue by Player (2019-2024)
3.1.2 Global Sterile Injectable CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Sterile Injectable CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 STERILE INJECTABLE CDMO BY REGION
4.1 Sterile Injectable CDMO Market Size by Region (2019-2024)
4.2 Global Sterile Injectable CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sterile Injectable CDMO Market Size Growth (2019-2024)
4.4 APAC Sterile Injectable CDMO Market Size Growth (2019-2024)
4.5 Europe Sterile Injectable CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Sterile Injectable CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sterile Injectable CDMO Market Size by Country (2019-2024)
5.2 Americas Sterile Injectable CDMO Market Size by Type (2019-2024)
5.3 Americas Sterile Injectable CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sterile Injectable CDMO Market Size by Region (2019-2024)
6.2 APAC Sterile Injectable CDMO Market Size by Type (2019-2024)
6.3 APAC Sterile Injectable CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sterile Injectable CDMO Market Size by Country (2019-2024)
7.2 Europe Sterile Injectable CDMO Market Size by Type (2019-2024)
7.3 Europe Sterile Injectable CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sterile Injectable CDMO by Region (2019-2024)
8.2 Middle East & Africa Sterile Injectable CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Sterile Injectable CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL STERILE INJECTABLE CDMO MARKET FORECAST
10.1 Global Sterile Injectable CDMO Forecast by Region (2025-2030)
10.1.1 Global Sterile Injectable CDMO Forecast by Region (2025-2030)
10.1.2 Americas Sterile Injectable CDMO Forecast
10.1.3 APAC Sterile Injectable CDMO Forecast
10.1.4 Europe Sterile Injectable CDMO Forecast
10.1.5 Middle East & Africa Sterile Injectable CDMO Forecast
10.2 Americas Sterile Injectable CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Sterile Injectable CDMO Forecast
10.2.2 Canada Market Sterile Injectable CDMO Forecast
10.2.3 Mexico Market Sterile Injectable CDMO Forecast
10.2.4 Brazil Market Sterile Injectable CDMO Forecast
10.3 APAC Sterile Injectable CDMO Forecast by Region (2025-2030)
10.3.1 China Sterile Injectable CDMO Market Forecast
10.3.2 Japan Market Sterile Injectable CDMO Forecast
10.3.3 Korea Market Sterile Injectable CDMO Forecast
10.3.4 Southeast Asia Market Sterile Injectable CDMO Forecast
10.3.5 India Market Sterile Injectable CDMO Forecast
10.3.6 Australia Market Sterile Injectable CDMO Forecast
10.4 Europe Sterile Injectable CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Sterile Injectable CDMO Forecast
10.4.2 France Market Sterile Injectable CDMO Forecast
10.4.3 UK Market Sterile Injectable CDMO Forecast
10.4.4 Italy Market Sterile Injectable CDMO Forecast
10.4.5 Russia Market Sterile Injectable CDMO Forecast
10.5 Middle East & Africa Sterile Injectable CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Sterile Injectable CDMO Forecast
10.5.2 South Africa Market Sterile Injectable CDMO Forecast
10.5.3 Israel Market Sterile Injectable CDMO Forecast
10.5.4 Turkey Market Sterile Injectable CDMO Forecast
10.6 Global Sterile Injectable CDMO Forecast by Type (2025-2030)
10.7 Global Sterile Injectable CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sterile Injectable CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbvie
11.1.1 Abbvie Company Information
11.1.2 Abbvie Sterile Injectable CDMO Product Offered
11.1.3 Abbvie Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbvie Main Business Overview
11.1.5 Abbvie Latest Developments
11.2 Famar
11.2.1 Famar Company Information
11.2.2 Famar Sterile Injectable CDMO Product Offered
11.2.3 Famar Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Famar Main Business Overview
11.2.5 Famar Latest Developments
11.3 Polfa Tarchomin
11.3.1 Polfa Tarchomin Company Information
11.3.2 Polfa Tarchomin Sterile Injectable CDMO Product Offered
11.3.3 Polfa Tarchomin Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Polfa Tarchomin Main Business Overview
11.3.5 Polfa Tarchomin Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Sterile Injectable CDMO Product Offered
11.4.3 Pfizer Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Quotient Sciences
11.5.1 Quotient Sciences Company Information
11.5.2 Quotient Sciences Sterile Injectable CDMO Product Offered
11.5.3 Quotient Sciences Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Quotient Sciences Main Business Overview
11.5.5 Quotient Sciences Latest Developments
11.6 Temad Co.
11.6.1 Temad Co. Company Information
11.6.2 Temad Co. Sterile Injectable CDMO Product Offered
11.6.3 Temad Co. Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Temad Co. Main Business Overview
11.6.5 Temad Co. Latest Developments
11.7 Tianjin Hankang Pharmaceutical Biotechnology
11.7.1 Tianjin Hankang Pharmaceutical Biotechnology Company Information
11.7.2 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Offered
11.7.3 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Tianjin Hankang Pharmaceutical Biotechnology Main Business Overview
11.7.5 Tianjin Hankang Pharmaceutical Biotechnology Latest Developments
11.8 Fareva
11.8.1 Fareva Company Information
11.8.2 Fareva Sterile Injectable CDMO Product Offered
11.8.3 Fareva Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fareva Main Business Overview
11.8.5 Fareva Latest Developments
11.9 Sharp
11.9.1 Sharp Company Information
11.9.2 Sharp Sterile Injectable CDMO Product Offered
11.9.3 Sharp Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sharp Main Business Overview
11.9.5 Sharp Latest Developments
11.10 Astral SteriTech
11.10.1 Astral SteriTech Company Information
11.10.2 Astral SteriTech Sterile Injectable CDMO Product Offered
11.10.3 Astral SteriTech Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Astral SteriTech Main Business Overview
11.10.5 Astral SteriTech Latest Developments
11.11 Evonik
11.11.1 Evonik Company Information
11.11.2 Evonik Sterile Injectable CDMO Product Offered
11.11.3 Evonik Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Evonik Main Business Overview
11.11.5 Evonik Latest Developments
11.12 Aurigene Pharmaceutical Services
11.12.1 Aurigene Pharmaceutical Services Company Information
11.12.2 Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Offered
11.12.3 Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Aurigene Pharmaceutical Services Main Business Overview
11.12.5 Aurigene Pharmaceutical Services Latest Developments
11.13 Prague Scientific
11.13.1 Prague Scientific Company Information
11.13.2 Prague Scientific Sterile Injectable CDMO Product Offered
11.13.3 Prague Scientific Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Prague Scientific Main Business Overview
11.13.5 Prague Scientific Latest Developments
11.14 Ethypharm
11.14.1 Ethypharm Company Information
11.14.2 Ethypharm Sterile Injectable CDMO Product Offered
11.14.3 Ethypharm Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ethypharm Main Business Overview
11.14.5 Ethypharm Latest Developments
11.15 TriRx Pharmaceutical Services
11.15.1 TriRx Pharmaceutical Services Company Information
11.15.2 TriRx Pharmaceutical Services Sterile Injectable CDMO Product Offered
11.15.3 TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 TriRx Pharmaceutical Services Main Business Overview
11.15.5 TriRx Pharmaceutical Services Latest Developments
11.16 Biophrama Group
11.16.1 Biophrama Group Company Information
11.16.2 Biophrama Group Sterile Injectable CDMO Product Offered
11.16.3 Biophrama Group Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Biophrama Group Main Business Overview
11.16.5 Biophrama Group Latest Developments
11.17 Gensenta Pharmaceuticals
11.17.1 Gensenta Pharmaceuticals Company Information
11.17.2 Gensenta Pharmaceuticals Sterile Injectable CDMO Product Offered
11.17.3 Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Gensenta Pharmaceuticals Main Business Overview
11.17.5 Gensenta Pharmaceuticals Latest Developments
11.18 BioTechnique
11.18.1 BioTechnique Company Information
11.18.2 BioTechnique Sterile Injectable CDMO Product Offered
11.18.3 BioTechnique Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 BioTechnique Main Business Overview
11.18.5 BioTechnique Latest Developments
11.19 Mithra CDMo
11.19.1 Mithra CDMo Company Information
11.19.2 Mithra CDMo Sterile Injectable CDMO Product Offered
11.19.3 Mithra CDMo Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mithra CDMo Main Business Overview
11.19.5 Mithra CDMo Latest Developments
11.20 S.C. Rompharm Company SRL
11.20.1 S.C. Rompharm Company SRL Company Information
11.20.2 S.C. Rompharm Company SRL Sterile Injectable CDMO Product Offered
11.20.3 S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 S.C. Rompharm Company SRL Main Business Overview
11.20.5 S.C. Rompharm Company SRL Latest Developments
11.21 Flagship Biotech International Pvt. Ltd
11.21.1 Flagship Biotech International Pvt. Ltd Company Information
11.21.2 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Offered
11.21.3 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Flagship Biotech International Pvt. Ltd Main Business Overview
11.21.5 Flagship Biotech International Pvt. Ltd Latest Developments
11.22 Curida AS
11.22.1 Curida AS Company Information
11.22.2 Curida AS Sterile Injectable CDMO Product Offered
11.22.3 Curida AS Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Curida AS Main Business Overview
11.22.5 Curida AS Latest Developments
11.23 BirgiMefar Group
11.23.1 BirgiMefar Group Company Information
11.23.2 BirgiMefar Group Sterile Injectable CDMO Product Offered
11.23.3 BirgiMefar Group Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 BirgiMefar Group Main Business Overview
11.23.5 BirgiMefar Group Latest Developments
11.24 Brooks Laboratories Limited
11.24.1 Brooks Laboratories Limited Company Information
11.24.2 Brooks Laboratories Limited Sterile Injectable CDMO Product Offered
11.24.3 Brooks Laboratories Limited Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Brooks Laboratories Limited Main Business Overview
11.24.5 Brooks Laboratories Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sterile Injectable CDMO Market Size 2019-2030
2.1.2 Sterile Injectable CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030)
2.1.3 World Current & Future Analysis for Sterile Injectable CDMO by Country/Region, 2019, 2023 & 2030
2.2 Sterile Injectable CDMO Segment by Type
2.2.1 Preclinical Manufacturing
2.2.2 Clinical Manufacturing
2.2.3 Commercial Manufacturing
2.3 Sterile Injectable CDMO Market Size by Type
2.3.1 Sterile Injectable CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
2.4 Sterile Injectable CDMO Segment by Application
2.4.1 Pharmaceutical Company
2.4.2 Research Institute
2.4.3 Other
2.5 Sterile Injectable CDMO Market Size by Application
2.5.1 Sterile Injectable CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
3 STERILE INJECTABLE CDMO MARKET SIZE BY PLAYER
3.1 Sterile Injectable CDMO Market Size Market Share by Player
3.1.1 Global Sterile Injectable CDMO Revenue by Player (2019-2024)
3.1.2 Global Sterile Injectable CDMO Revenue Market Share by Player (2019-2024)
3.2 Global Sterile Injectable CDMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 STERILE INJECTABLE CDMO BY REGION
4.1 Sterile Injectable CDMO Market Size by Region (2019-2024)
4.2 Global Sterile Injectable CDMO Annual Revenue by Country/Region (2019-2024)
4.3 Americas Sterile Injectable CDMO Market Size Growth (2019-2024)
4.4 APAC Sterile Injectable CDMO Market Size Growth (2019-2024)
4.5 Europe Sterile Injectable CDMO Market Size Growth (2019-2024)
4.6 Middle East & Africa Sterile Injectable CDMO Market Size Growth (2019-2024)
5 AMERICAS
5.1 Americas Sterile Injectable CDMO Market Size by Country (2019-2024)
5.2 Americas Sterile Injectable CDMO Market Size by Type (2019-2024)
5.3 Americas Sterile Injectable CDMO Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sterile Injectable CDMO Market Size by Region (2019-2024)
6.2 APAC Sterile Injectable CDMO Market Size by Type (2019-2024)
6.3 APAC Sterile Injectable CDMO Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sterile Injectable CDMO Market Size by Country (2019-2024)
7.2 Europe Sterile Injectable CDMO Market Size by Type (2019-2024)
7.3 Europe Sterile Injectable CDMO Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sterile Injectable CDMO by Region (2019-2024)
8.2 Middle East & Africa Sterile Injectable CDMO Market Size by Type (2019-2024)
8.3 Middle East & Africa Sterile Injectable CDMO Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL STERILE INJECTABLE CDMO MARKET FORECAST
10.1 Global Sterile Injectable CDMO Forecast by Region (2025-2030)
10.1.1 Global Sterile Injectable CDMO Forecast by Region (2025-2030)
10.1.2 Americas Sterile Injectable CDMO Forecast
10.1.3 APAC Sterile Injectable CDMO Forecast
10.1.4 Europe Sterile Injectable CDMO Forecast
10.1.5 Middle East & Africa Sterile Injectable CDMO Forecast
10.2 Americas Sterile Injectable CDMO Forecast by Country (2025-2030)
10.2.1 United States Market Sterile Injectable CDMO Forecast
10.2.2 Canada Market Sterile Injectable CDMO Forecast
10.2.3 Mexico Market Sterile Injectable CDMO Forecast
10.2.4 Brazil Market Sterile Injectable CDMO Forecast
10.3 APAC Sterile Injectable CDMO Forecast by Region (2025-2030)
10.3.1 China Sterile Injectable CDMO Market Forecast
10.3.2 Japan Market Sterile Injectable CDMO Forecast
10.3.3 Korea Market Sterile Injectable CDMO Forecast
10.3.4 Southeast Asia Market Sterile Injectable CDMO Forecast
10.3.5 India Market Sterile Injectable CDMO Forecast
10.3.6 Australia Market Sterile Injectable CDMO Forecast
10.4 Europe Sterile Injectable CDMO Forecast by Country (2025-2030)
10.4.1 Germany Market Sterile Injectable CDMO Forecast
10.4.2 France Market Sterile Injectable CDMO Forecast
10.4.3 UK Market Sterile Injectable CDMO Forecast
10.4.4 Italy Market Sterile Injectable CDMO Forecast
10.4.5 Russia Market Sterile Injectable CDMO Forecast
10.5 Middle East & Africa Sterile Injectable CDMO Forecast by Region (2025-2030)
10.5.1 Egypt Market Sterile Injectable CDMO Forecast
10.5.2 South Africa Market Sterile Injectable CDMO Forecast
10.5.3 Israel Market Sterile Injectable CDMO Forecast
10.5.4 Turkey Market Sterile Injectable CDMO Forecast
10.6 Global Sterile Injectable CDMO Forecast by Type (2025-2030)
10.7 Global Sterile Injectable CDMO Forecast by Application (2025-2030)
10.7.1 GCC Countries Market Sterile Injectable CDMO Forecast
11 KEY PLAYERS ANALYSIS
11.1 Abbvie
11.1.1 Abbvie Company Information
11.1.2 Abbvie Sterile Injectable CDMO Product Offered
11.1.3 Abbvie Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbvie Main Business Overview
11.1.5 Abbvie Latest Developments
11.2 Famar
11.2.1 Famar Company Information
11.2.2 Famar Sterile Injectable CDMO Product Offered
11.2.3 Famar Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Famar Main Business Overview
11.2.5 Famar Latest Developments
11.3 Polfa Tarchomin
11.3.1 Polfa Tarchomin Company Information
11.3.2 Polfa Tarchomin Sterile Injectable CDMO Product Offered
11.3.3 Polfa Tarchomin Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Polfa Tarchomin Main Business Overview
11.3.5 Polfa Tarchomin Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Sterile Injectable CDMO Product Offered
11.4.3 Pfizer Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Quotient Sciences
11.5.1 Quotient Sciences Company Information
11.5.2 Quotient Sciences Sterile Injectable CDMO Product Offered
11.5.3 Quotient Sciences Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Quotient Sciences Main Business Overview
11.5.5 Quotient Sciences Latest Developments
11.6 Temad Co.
11.6.1 Temad Co. Company Information
11.6.2 Temad Co. Sterile Injectable CDMO Product Offered
11.6.3 Temad Co. Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Temad Co. Main Business Overview
11.6.5 Temad Co. Latest Developments
11.7 Tianjin Hankang Pharmaceutical Biotechnology
11.7.1 Tianjin Hankang Pharmaceutical Biotechnology Company Information
11.7.2 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Offered
11.7.3 Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Tianjin Hankang Pharmaceutical Biotechnology Main Business Overview
11.7.5 Tianjin Hankang Pharmaceutical Biotechnology Latest Developments
11.8 Fareva
11.8.1 Fareva Company Information
11.8.2 Fareva Sterile Injectable CDMO Product Offered
11.8.3 Fareva Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Fareva Main Business Overview
11.8.5 Fareva Latest Developments
11.9 Sharp
11.9.1 Sharp Company Information
11.9.2 Sharp Sterile Injectable CDMO Product Offered
11.9.3 Sharp Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Sharp Main Business Overview
11.9.5 Sharp Latest Developments
11.10 Astral SteriTech
11.10.1 Astral SteriTech Company Information
11.10.2 Astral SteriTech Sterile Injectable CDMO Product Offered
11.10.3 Astral SteriTech Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Astral SteriTech Main Business Overview
11.10.5 Astral SteriTech Latest Developments
11.11 Evonik
11.11.1 Evonik Company Information
11.11.2 Evonik Sterile Injectable CDMO Product Offered
11.11.3 Evonik Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 Evonik Main Business Overview
11.11.5 Evonik Latest Developments
11.12 Aurigene Pharmaceutical Services
11.12.1 Aurigene Pharmaceutical Services Company Information
11.12.2 Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Offered
11.12.3 Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Aurigene Pharmaceutical Services Main Business Overview
11.12.5 Aurigene Pharmaceutical Services Latest Developments
11.13 Prague Scientific
11.13.1 Prague Scientific Company Information
11.13.2 Prague Scientific Sterile Injectable CDMO Product Offered
11.13.3 Prague Scientific Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Prague Scientific Main Business Overview
11.13.5 Prague Scientific Latest Developments
11.14 Ethypharm
11.14.1 Ethypharm Company Information
11.14.2 Ethypharm Sterile Injectable CDMO Product Offered
11.14.3 Ethypharm Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ethypharm Main Business Overview
11.14.5 Ethypharm Latest Developments
11.15 TriRx Pharmaceutical Services
11.15.1 TriRx Pharmaceutical Services Company Information
11.15.2 TriRx Pharmaceutical Services Sterile Injectable CDMO Product Offered
11.15.3 TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 TriRx Pharmaceutical Services Main Business Overview
11.15.5 TriRx Pharmaceutical Services Latest Developments
11.16 Biophrama Group
11.16.1 Biophrama Group Company Information
11.16.2 Biophrama Group Sterile Injectable CDMO Product Offered
11.16.3 Biophrama Group Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Biophrama Group Main Business Overview
11.16.5 Biophrama Group Latest Developments
11.17 Gensenta Pharmaceuticals
11.17.1 Gensenta Pharmaceuticals Company Information
11.17.2 Gensenta Pharmaceuticals Sterile Injectable CDMO Product Offered
11.17.3 Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Gensenta Pharmaceuticals Main Business Overview
11.17.5 Gensenta Pharmaceuticals Latest Developments
11.18 BioTechnique
11.18.1 BioTechnique Company Information
11.18.2 BioTechnique Sterile Injectable CDMO Product Offered
11.18.3 BioTechnique Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 BioTechnique Main Business Overview
11.18.5 BioTechnique Latest Developments
11.19 Mithra CDMo
11.19.1 Mithra CDMo Company Information
11.19.2 Mithra CDMo Sterile Injectable CDMO Product Offered
11.19.3 Mithra CDMo Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Mithra CDMo Main Business Overview
11.19.5 Mithra CDMo Latest Developments
11.20 S.C. Rompharm Company SRL
11.20.1 S.C. Rompharm Company SRL Company Information
11.20.2 S.C. Rompharm Company SRL Sterile Injectable CDMO Product Offered
11.20.3 S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 S.C. Rompharm Company SRL Main Business Overview
11.20.5 S.C. Rompharm Company SRL Latest Developments
11.21 Flagship Biotech International Pvt. Ltd
11.21.1 Flagship Biotech International Pvt. Ltd Company Information
11.21.2 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Offered
11.21.3 Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Flagship Biotech International Pvt. Ltd Main Business Overview
11.21.5 Flagship Biotech International Pvt. Ltd Latest Developments
11.22 Curida AS
11.22.1 Curida AS Company Information
11.22.2 Curida AS Sterile Injectable CDMO Product Offered
11.22.3 Curida AS Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Curida AS Main Business Overview
11.22.5 Curida AS Latest Developments
11.23 BirgiMefar Group
11.23.1 BirgiMefar Group Company Information
11.23.2 BirgiMefar Group Sterile Injectable CDMO Product Offered
11.23.3 BirgiMefar Group Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.23.4 BirgiMefar Group Main Business Overview
11.23.5 BirgiMefar Group Latest Developments
11.24 Brooks Laboratories Limited
11.24.1 Brooks Laboratories Limited Company Information
11.24.2 Brooks Laboratories Limited Sterile Injectable CDMO Product Offered
11.24.3 Brooks Laboratories Limited Sterile Injectable CDMO Revenue, Gross Margin and Market Share (2019-2024)
11.24.4 Brooks Laboratories Limited Main Business Overview
11.24.5 Brooks Laboratories Limited Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sterile Injectable CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sterile Injectable CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preclinical Manufacturing
Table 4. Major Players of Clinical Manufacturing
Table 5. Major Players of Commercial Manufacturing
Table 6. Sterile Injectable CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Table 9. Sterile Injectable CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Table 12. Global Sterile Injectable CDMO Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Sterile Injectable CDMO Revenue Market Share by Player (2019-2024)
Table 14. Sterile Injectable CDMO Key Players Head office and Products Offered
Table 15. Sterile Injectable CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Table 20. Global Sterile Injectable CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Sterile Injectable CDMO Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Sterile Injectable CDMO Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Sterile Injectable CDMO Market Size Market Share by Country (2019-2024)
Table 24. Americas Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Table 26. Americas Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Table 28. APAC Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Table 30. APAC Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Sterile Injectable CDMO Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Sterile Injectable CDMO Market Size Market Share by Country (2019-2024)
Table 34. Europe Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sterile Injectable CDMO
Table 40. Key Market Challenges & Risks of Sterile Injectable CDMO
Table 41. Key Industry Trends of Sterile Injectable CDMO
Table 42. Global Sterile Injectable CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Sterile Injectable CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Sterile Injectable CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Sterile Injectable CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Abbvie Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 47. Abbvie Sterile Injectable CDMO Product Offered
Table 48. Abbvie Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Abbvie Main Business
Table 50. Abbvie Latest Developments
Table 51. Famar Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 52. Famar Sterile Injectable CDMO Product Offered
Table 53. Famar Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Famar Main Business
Table 55. Famar Latest Developments
Table 56. Polfa Tarchomin Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 57. Polfa Tarchomin Sterile Injectable CDMO Product Offered
Table 58. Polfa Tarchomin Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Polfa Tarchomin Main Business
Table 60. Polfa Tarchomin Latest Developments
Table 61. Pfizer Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 62. Pfizer Sterile Injectable CDMO Product Offered
Table 63. Pfizer Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. Quotient Sciences Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 67. Quotient Sciences Sterile Injectable CDMO Product Offered
Table 68. Quotient Sciences Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Quotient Sciences Main Business
Table 70. Quotient Sciences Latest Developments
Table 71. Temad Co. Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 72. Temad Co. Sterile Injectable CDMO Product Offered
Table 73. Temad Co. Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Temad Co. Main Business
Table 75. Temad Co. Latest Developments
Table 76. Tianjin Hankang Pharmaceutical Biotechnology Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 77. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Offered
Table 78. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Tianjin Hankang Pharmaceutical Biotechnology Main Business
Table 80. Tianjin Hankang Pharmaceutical Biotechnology Latest Developments
Table 81. Fareva Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 82. Fareva Sterile Injectable CDMO Product Offered
Table 83. Fareva Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Fareva Main Business
Table 85. Fareva Latest Developments
Table 86. Sharp Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 87. Sharp Sterile Injectable CDMO Product Offered
Table 88. Sharp Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Sharp Main Business
Table 90. Sharp Latest Developments
Table 91. Astral SteriTech Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 92. Astral SteriTech Sterile Injectable CDMO Product Offered
Table 93. Astral SteriTech Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Astral SteriTech Main Business
Table 95. Astral SteriTech Latest Developments
Table 96. Evonik Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 97. Evonik Sterile Injectable CDMO Product Offered
Table 98. Evonik Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Evonik Main Business
Table 100. Evonik Latest Developments
Table 101. Aurigene Pharmaceutical Services Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 102. Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Offered
Table 103. Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Aurigene Pharmaceutical Services Main Business
Table 105. Aurigene Pharmaceutical Services Latest Developments
Table 106. Prague Scientific Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 107. Prague Scientific Sterile Injectable CDMO Product Offered
Table 108. Prague Scientific Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Prague Scientific Main Business
Table 110. Prague Scientific Latest Developments
Table 111. Ethypharm Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 112. Ethypharm Sterile Injectable CDMO Product Offered
Table 113. Ethypharm Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Ethypharm Main Business
Table 115. Ethypharm Latest Developments
Table 116. TriRx Pharmaceutical Services Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 117. TriRx Pharmaceutical Services Sterile Injectable CDMO Product Offered
Table 118. TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. TriRx Pharmaceutical Services Main Business
Table 120. TriRx Pharmaceutical Services Latest Developments
Table 121. Biophrama Group Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 122. Biophrama Group Sterile Injectable CDMO Product Offered
Table 123. Biophrama Group Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Biophrama Group Main Business
Table 125. Biophrama Group Latest Developments
Table 126. Gensenta Pharmaceuticals Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 127. Gensenta Pharmaceuticals Sterile Injectable CDMO Product Offered
Table 128. Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Gensenta Pharmaceuticals Main Business
Table 130. Gensenta Pharmaceuticals Latest Developments
Table 131. BioTechnique Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 132. BioTechnique Sterile Injectable CDMO Product Offered
Table 133. BioTechnique Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. BioTechnique Main Business
Table 135. BioTechnique Latest Developments
Table 136. Mithra CDMo Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 137. Mithra CDMo Sterile Injectable CDMO Product Offered
Table 138. Mithra CDMo Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Mithra CDMo Main Business
Table 140. Mithra CDMo Latest Developments
Table 141. S.C. Rompharm Company SRL Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 142. S.C. Rompharm Company SRL Sterile Injectable CDMO Product Offered
Table 143. S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. S.C. Rompharm Company SRL Main Business
Table 145. S.C. Rompharm Company SRL Latest Developments
Table 146. Flagship Biotech International Pvt. Ltd Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 147. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Offered
Table 148. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Flagship Biotech International Pvt. Ltd Main Business
Table 150. Flagship Biotech International Pvt. Ltd Latest Developments
Table 151. Curida AS Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 152. Curida AS Sterile Injectable CDMO Product Offered
Table 153. Curida AS Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Curida AS Main Business
Table 155. Curida AS Latest Developments
Table 156. BirgiMefar Group Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 157. BirgiMefar Group Sterile Injectable CDMO Product Offered
Table 158. BirgiMefar Group Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 159. BirgiMefar Group Main Business
Table 160. BirgiMefar Group Latest Developments
Table 161. Brooks Laboratories Limited Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 162. Brooks Laboratories Limited Sterile Injectable CDMO Product Offered
Table 163. Brooks Laboratories Limited Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 164. Brooks Laboratories Limited Main Business
Table 165. Brooks Laboratories Limited Latest Developments
Table 1. Sterile Injectable CDMO Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ millions)
Table 2. Sterile Injectable CDMO Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Preclinical Manufacturing
Table 4. Major Players of Clinical Manufacturing
Table 5. Major Players of Commercial Manufacturing
Table 6. Sterile Injectable CDMO Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ millions)
Table 7. Global Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 8. Global Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Table 9. Sterile Injectable CDMO Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ millions)
Table 10. Global Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 11. Global Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Table 12. Global Sterile Injectable CDMO Revenue by Player (2019-2024) & ($ millions)
Table 13. Global Sterile Injectable CDMO Revenue Market Share by Player (2019-2024)
Table 14. Sterile Injectable CDMO Key Players Head office and Products Offered
Table 15. Sterile Injectable CDMO Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 19. Global Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Table 20. Global Sterile Injectable CDMO Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global Sterile Injectable CDMO Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas Sterile Injectable CDMO Market Size by Country (2019-2024) & ($ millions)
Table 23. Americas Sterile Injectable CDMO Market Size Market Share by Country (2019-2024)
Table 24. Americas Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 25. Americas Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Table 26. Americas Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 27. Americas Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Table 28. APAC Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 29. APAC Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Table 30. APAC Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 31. APAC Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 32. Europe Sterile Injectable CDMO Market Size by Country (2019-2024) & ($ millions)
Table 33. Europe Sterile Injectable CDMO Market Size Market Share by Country (2019-2024)
Table 34. Europe Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 35. Europe Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 36. Middle East & Africa Sterile Injectable CDMO Market Size by Region (2019-2024) & ($ millions)
Table 37. Middle East & Africa Sterile Injectable CDMO Market Size by Type (2019-2024) & ($ millions)
Table 38. Middle East & Africa Sterile Injectable CDMO Market Size by Application (2019-2024) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Sterile Injectable CDMO
Table 40. Key Market Challenges & Risks of Sterile Injectable CDMO
Table 41. Key Industry Trends of Sterile Injectable CDMO
Table 42. Global Sterile Injectable CDMO Market Size Forecast by Region (2025-2030) & ($ millions)
Table 43. Global Sterile Injectable CDMO Market Size Market Share Forecast by Region (2025-2030)
Table 44. Global Sterile Injectable CDMO Market Size Forecast by Type (2025-2030) & ($ millions)
Table 45. Global Sterile Injectable CDMO Market Size Forecast by Application (2025-2030) & ($ millions)
Table 46. Abbvie Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 47. Abbvie Sterile Injectable CDMO Product Offered
Table 48. Abbvie Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 49. Abbvie Main Business
Table 50. Abbvie Latest Developments
Table 51. Famar Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 52. Famar Sterile Injectable CDMO Product Offered
Table 53. Famar Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Famar Main Business
Table 55. Famar Latest Developments
Table 56. Polfa Tarchomin Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 57. Polfa Tarchomin Sterile Injectable CDMO Product Offered
Table 58. Polfa Tarchomin Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 59. Polfa Tarchomin Main Business
Table 60. Polfa Tarchomin Latest Developments
Table 61. Pfizer Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 62. Pfizer Sterile Injectable CDMO Product Offered
Table 63. Pfizer Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 64. Pfizer Main Business
Table 65. Pfizer Latest Developments
Table 66. Quotient Sciences Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 67. Quotient Sciences Sterile Injectable CDMO Product Offered
Table 68. Quotient Sciences Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 69. Quotient Sciences Main Business
Table 70. Quotient Sciences Latest Developments
Table 71. Temad Co. Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 72. Temad Co. Sterile Injectable CDMO Product Offered
Table 73. Temad Co. Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 74. Temad Co. Main Business
Table 75. Temad Co. Latest Developments
Table 76. Tianjin Hankang Pharmaceutical Biotechnology Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 77. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Product Offered
Table 78. Tianjin Hankang Pharmaceutical Biotechnology Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 79. Tianjin Hankang Pharmaceutical Biotechnology Main Business
Table 80. Tianjin Hankang Pharmaceutical Biotechnology Latest Developments
Table 81. Fareva Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 82. Fareva Sterile Injectable CDMO Product Offered
Table 83. Fareva Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 84. Fareva Main Business
Table 85. Fareva Latest Developments
Table 86. Sharp Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 87. Sharp Sterile Injectable CDMO Product Offered
Table 88. Sharp Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 89. Sharp Main Business
Table 90. Sharp Latest Developments
Table 91. Astral SteriTech Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 92. Astral SteriTech Sterile Injectable CDMO Product Offered
Table 93. Astral SteriTech Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 94. Astral SteriTech Main Business
Table 95. Astral SteriTech Latest Developments
Table 96. Evonik Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 97. Evonik Sterile Injectable CDMO Product Offered
Table 98. Evonik Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 99. Evonik Main Business
Table 100. Evonik Latest Developments
Table 101. Aurigene Pharmaceutical Services Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 102. Aurigene Pharmaceutical Services Sterile Injectable CDMO Product Offered
Table 103. Aurigene Pharmaceutical Services Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 104. Aurigene Pharmaceutical Services Main Business
Table 105. Aurigene Pharmaceutical Services Latest Developments
Table 106. Prague Scientific Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 107. Prague Scientific Sterile Injectable CDMO Product Offered
Table 108. Prague Scientific Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 109. Prague Scientific Main Business
Table 110. Prague Scientific Latest Developments
Table 111. Ethypharm Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 112. Ethypharm Sterile Injectable CDMO Product Offered
Table 113. Ethypharm Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 114. Ethypharm Main Business
Table 115. Ethypharm Latest Developments
Table 116. TriRx Pharmaceutical Services Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 117. TriRx Pharmaceutical Services Sterile Injectable CDMO Product Offered
Table 118. TriRx Pharmaceutical Services Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 119. TriRx Pharmaceutical Services Main Business
Table 120. TriRx Pharmaceutical Services Latest Developments
Table 121. Biophrama Group Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 122. Biophrama Group Sterile Injectable CDMO Product Offered
Table 123. Biophrama Group Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 124. Biophrama Group Main Business
Table 125. Biophrama Group Latest Developments
Table 126. Gensenta Pharmaceuticals Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 127. Gensenta Pharmaceuticals Sterile Injectable CDMO Product Offered
Table 128. Gensenta Pharmaceuticals Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 129. Gensenta Pharmaceuticals Main Business
Table 130. Gensenta Pharmaceuticals Latest Developments
Table 131. BioTechnique Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 132. BioTechnique Sterile Injectable CDMO Product Offered
Table 133. BioTechnique Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 134. BioTechnique Main Business
Table 135. BioTechnique Latest Developments
Table 136. Mithra CDMo Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 137. Mithra CDMo Sterile Injectable CDMO Product Offered
Table 138. Mithra CDMo Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 139. Mithra CDMo Main Business
Table 140. Mithra CDMo Latest Developments
Table 141. S.C. Rompharm Company SRL Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 142. S.C. Rompharm Company SRL Sterile Injectable CDMO Product Offered
Table 143. S.C. Rompharm Company SRL Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 144. S.C. Rompharm Company SRL Main Business
Table 145. S.C. Rompharm Company SRL Latest Developments
Table 146. Flagship Biotech International Pvt. Ltd Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 147. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Product Offered
Table 148. Flagship Biotech International Pvt. Ltd Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 149. Flagship Biotech International Pvt. Ltd Main Business
Table 150. Flagship Biotech International Pvt. Ltd Latest Developments
Table 151. Curida AS Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 152. Curida AS Sterile Injectable CDMO Product Offered
Table 153. Curida AS Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 154. Curida AS Main Business
Table 155. Curida AS Latest Developments
Table 156. BirgiMefar Group Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 157. BirgiMefar Group Sterile Injectable CDMO Product Offered
Table 158. BirgiMefar Group Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 159. BirgiMefar Group Main Business
Table 160. BirgiMefar Group Latest Developments
Table 161. Brooks Laboratories Limited Details, Company Type, Sterile Injectable CDMO Area Served and Its Competitors
Table 162. Brooks Laboratories Limited Sterile Injectable CDMO Product Offered
Table 163. Brooks Laboratories Limited Sterile Injectable CDMO Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 164. Brooks Laboratories Limited Main Business
Table 165. Brooks Laboratories Limited Latest Developments
LIST OF FIGURES
Figure 1. Sterile Injectable CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sterile Injectable CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sterile Injectable CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sterile Injectable CDMO Sales Market Share by Country/Region (2023)
Figure 8. Sterile Injectable CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sterile Injectable CDMO Market Size Market Share by Type in 2023
Figure 10. Sterile Injectable CDMO in Pharmaceutical Company
Figure 11. Global Sterile Injectable CDMO Market: Pharmaceutical Company (2019-2024) & ($ millions)
Figure 12. Sterile Injectable CDMO in Research Institute
Figure 13. Global Sterile Injectable CDMO Market: Research Institute (2019-2024) & ($ millions)
Figure 14. Sterile Injectable CDMO in Other
Figure 15. Global Sterile Injectable CDMO Market: Other (2019-2024) & ($ millions)
Figure 16. Global Sterile Injectable CDMO Market Size Market Share by Application in 2023
Figure 17. Global Sterile Injectable CDMO Revenue Market Share by Player in 2023
Figure 18. Global Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Figure 19. Americas Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 20. APAC Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 21. Europe Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 23. Americas Sterile Injectable CDMO Value Market Share by Country in 2023
Figure 24. United States Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Sterile Injectable CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 30. APAC Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 31. China Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. India Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Sterile Injectable CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41. France Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 54. APAC Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 55. Europe Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 57. United States Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 58. Canada Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 59. Mexico Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 60. Brazil Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 61. China Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 62. Japan Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 63. Korea Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 65. India Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 66. Australia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 67. Germany Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 68. France Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 69. UK Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 70. Italy Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 71. Russia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 72. Egypt Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 73. South Africa Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 74. Israel Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 75. Turkey Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 77. Global Sterile Injectable CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Sterile Injectable CDMO Market Size Market Share Forecast by Application (2025-2030)
Figure 1. Sterile Injectable CDMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sterile Injectable CDMO Market Size Growth Rate 2019-2030 ($ millions)
Figure 6. Sterile Injectable CDMO Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Sterile Injectable CDMO Sales Market Share by Country/Region (2023)
Figure 8. Sterile Injectable CDMO Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Sterile Injectable CDMO Market Size Market Share by Type in 2023
Figure 10. Sterile Injectable CDMO in Pharmaceutical Company
Figure 11. Global Sterile Injectable CDMO Market: Pharmaceutical Company (2019-2024) & ($ millions)
Figure 12. Sterile Injectable CDMO in Research Institute
Figure 13. Global Sterile Injectable CDMO Market: Research Institute (2019-2024) & ($ millions)
Figure 14. Sterile Injectable CDMO in Other
Figure 15. Global Sterile Injectable CDMO Market: Other (2019-2024) & ($ millions)
Figure 16. Global Sterile Injectable CDMO Market Size Market Share by Application in 2023
Figure 17. Global Sterile Injectable CDMO Revenue Market Share by Player in 2023
Figure 18. Global Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Figure 19. Americas Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 20. APAC Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 21. Europe Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 22. Middle East & Africa Sterile Injectable CDMO Market Size 2019-2024 ($ millions)
Figure 23. Americas Sterile Injectable CDMO Value Market Share by Country in 2023
Figure 24. United States Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 25. Canada Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 26. Mexico Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 27. Brazil Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 28. APAC Sterile Injectable CDMO Market Size Market Share by Region in 2023
Figure 29. APAC Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 30. APAC Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 31. China Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 32. Japan Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 33. South Korea Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 34. Southeast Asia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 35. India Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 36. Australia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 37. Europe Sterile Injectable CDMO Market Size Market Share by Country in 2023
Figure 38. Europe Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 39. Europe Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 40. Germany Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 41. France Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 42. UK Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 43. Italy Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 44. Russia Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 45. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Sterile Injectable CDMO Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 49. South Africa Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 50. Israel Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 51. Turkey Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 52. GCC Countries Sterile Injectable CDMO Market Size Growth 2019-2024 ($ millions)
Figure 53. Americas Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 54. APAC Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 55. Europe Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 56. Middle East & Africa Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 57. United States Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 58. Canada Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 59. Mexico Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 60. Brazil Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 61. China Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 62. Japan Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 63. Korea Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 64. Southeast Asia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 65. India Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 66. Australia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 67. Germany Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 68. France Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 69. UK Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 70. Italy Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 71. Russia Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 72. Egypt Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 73. South Africa Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 74. Israel Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 75. Turkey Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 76. GCC Countries Sterile Injectable CDMO Market Size 2025-2030 ($ millions)
Figure 77. Global Sterile Injectable CDMO Market Size Market Share Forecast by Type (2025-2030)
Figure 78. Global Sterile Injectable CDMO Market Size Market Share Forecast by Application (2025-2030)
